RECITALSExecutive Employment Agreement • February 1st, 2005 • Dyadic International Inc • Services-commercial physical & biological research
and GENEVA INVESTMENT HOLDINGS LIMITED as Purchaser AGREEMENT relating to the sale and purchase of 70% of the entire issued share capital of ** EDE CHARLTON 13/F Wing On Centre 111 Connaught Road Central Hong Kong Tel: 852 2905 7888 Fax: 852 2854 9596...Agreement • January 20th, 2005 • Dyadic International Inc • Services-commercial physical & biological research
RECITALS:Indemnification Agreement • April 28th, 2005 • Dyadic International Inc • Services-commercial physical & biological research • Delaware
FORM OF SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT SUBSCRIPTION AGREEMENT ("Subscription Agreement") made as of this __ day of __________________, 2004, by and among CCP Worldwide, Inc., a Delaware corporation (the "Company"), Dyadic International,...Subscription Agreement • November 5th, 2004 • CCP Worldwide Inc • Plastics foam products • Delaware
ARTICLE I DEFINITIONSDevelopment Agreement • January 20th, 2005 • Dyadic International Inc • Services-commercial physical & biological research • Delaware
Exhibit 10.2 Common Stock PURCHASE AGREEMENTStock Purchase Agreement • July 3rd, 2003 • CCP Worldwide Inc • Plastics foam products • New York
RECITALSExecutive Employment Agreement • April 1st, 2005 • Dyadic International Inc • Services-commercial physical & biological research • Florida
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 13th, 2020 • Dyadic International Inc • Biological products, (no disgnostic substances) • New York
RECITALSIndemnification and Escrow Agreement • November 5th, 2004 • CCP Worldwide Inc • Plastics foam products • Delaware
ANDAgreement of Merger and Plan of Reorganization • September 30th, 2004 • CCP Worldwide Inc • Plastics foam products • Delaware
DYADIC INTERNATIONAL, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Delaware
THIS INDEMNIFICATION AGREEMENT (this "Agreement") is made as of the __ day of ____, ____, by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the "Company"), and [NAME OF OFFICER OR DIRECTOR] ("Indemnitee").
EXECUTION VERSION SPLIT-OFF AGREEMENT THE SPLIT-OFF AGREEMENT (this "Agreement") is made and entered into this 28th day of September, 2004, by and between CCP Worldwide, Inc., a Delaware corporation ("Seller"), David R. Allison ("Purchaser"), Custom...Split-Off Agreement • November 5th, 2004 • CCP Worldwide Inc • Plastics foam products • Delaware
RECITALS:Indemnification Agreement • April 1st, 2005 • Dyadic International Inc • Services-commercial physical & biological research • Delaware
RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
RESTRICTED STOCK AGREEMENT made this ___________ day of ___________ by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the “Company”), ___________ (“Stockholder”).
INTRACOASTAL POINTE OFFICE BUILDING LEASE AGREEMENTLease Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
THIS LEASE AGREEMENT (sometimes hereinafter referred to as the "Lease") is made and entered into this 30th day of December, 2010 by and between Quentin Partners Co. as Agent for lntracoastal Pointe, Inc., (Florida corporations) (hereinafter collectively called "Landlord"), whose address for purposes hereof is 851 S.E. Johnson Avenue, Suite 100, Stuart, Florida 34994; and Dyadic International, Inc., (hereinafter called "Tenant"). Tenant's address, for purposes hereof until commencement of the term of this Lease, being 140 lntracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 and thereafter being that of the Leased Premises (hereinafter defined).
EMPLOYMENT AGREEMENTEmployment Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of May 1, 2016 by and between DYADIC INTERNATIONAL, INC., a Delaware corporation, with its principal place of business at 140 lntracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 (the "Company"), and THOMAS L. DUBINSKI, a resident of Florida ("Employee"). (The Company and Employee are sometimes hereinafter jointly referred to as the "parties" and individually as a "party.")
DYADIC INTERNATIONAL, INC. Form of Option Agreement for 2006 Stock Option Plan DYADIC INTERNATIONAL, INC.Stock Option Grant Agreement • June 15th, 2006 • Dyadic International Inc • Services-commercial physical & biological research • Florida
This STOCK OPTION GRANT AGREEMENT (this “Agreement”), dated as of the ___ day of [INSERT DATE], 2006 (the “Date of Grant”), is delivered by Dyadic International, Inc. (the “Company”) to [INSERT GRANTEE’S NAME] (the “Grantee”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 21st, 2006 • Dyadic International Inc • Services-commercial physical & biological research • New York
For purposes of this opinion letter, the documents and information referred to in this Section A are collectively referred to as the “Documents.”
RECITALS:Indemnification Agreement • January 14th, 2005 • Dyadic International Inc • Services-commercial physical & biological research • Delaware
indicates that a confidential portion of the text of this agreement has been omitted. The non-publicMutual Nondisclosure Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Bern
EMPLOYMENT AGREEMENTEmployment Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
EMPLOYMENT AGREEMENT ("Agreement") made this 16th day of June, 2016 by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the "Company"), and MARK A. EMALFARB, a resident of the State of Florida (the "Executive").
INVESTMENT AGREEMENT with respect toShareholders Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
Hereinafter the persons and companies identified in items (1) through (9) will be jointly referred to as the “Existing Shareholders”.
LICENSE AGREEMENTLicense Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
WHEREAS, VTT has developed certain technology related to expression systems for micro- organisms and to promoters in expression systems;
CONSULTANT AGREEMENTConsultant Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
THIS CONSULTANT AGREEMENT ("Agreement") is made and entered as of the 1st day of January, 2016 ("Effective Date") by and between DYADIC NEDERLAND B.V. (the "Company"), and Sky Blue Biotech kft. ("Consultant"). As part of the Agreement, Consultant is required to engage Ronen Tchelet, an individual born on July 20, 1957 and currently residing in Budapest, Hungary. Ronen Tchelet shall be personally bound by the same obligations and covenants of Consultant in this agreement. The Company and Consultant are each sometimes individually referred to as a "Party" and collectively, as the "Parties." Capitalized terms used herein shall have the meaning provided in this Agreement including, but not limited to, as set forth in Section 5.8 hereof.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
This RESEARCH SERVICES AGREEMENT (this “Agreement”), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 (“Dyadic”), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 47151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 (“BDI Pharmaceuticals”). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.
CONSULTING AGREEMENTConsulting Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals
THIS CONSULTING AGREEMENT (“Agreement”) is made and entered as of the 13th day of March, 2017 (“Effective Date”) by and between Dyadic International, Inc. (the “Company”), and Novaro Ltd – acting as the Consulting Company Provider (the “Provider”). The Company and Provider are each sometimes individually referred to as a “Party” and collectively, as the “Parties.” Capitalized terms used herein shall have the meaning provided in this Agreement including, but not limited to, as set forth in Section 5.8 hereof.
AMENDED AND RESTATED NON-EXCLUSIVE SUBLICENSE AGREEMENTNon-Exclusive Sublicense Agreement • June 29th, 2020 • Dyadic International Inc • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Non-Exclusive Sublicense Agreement (“Agreement”) is entered into as of this 24th day of June, 2020 (“Effective Date”) by and between Dyadic International Inc., a Delaware corporation having its principal office at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477 (“Sublicensor”), and Alphazyme LLC a Delaware limited liability company having its principal office at 225 Chimney Corner Lane, Suite 3021, Jupiter, Florida 33458 (“Sublicensee”).
PHARMA LICENSE AGREEMENTPharma License Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Delaware
This PHARMA LICENSE AGREEMENT (the “Agreement”) is made as of December 31, 2015, and effective as of the Effective Date (as that term is defined below) by and between Danisco US, Inc., a Delaware corporation having a place of business at Building 356, DuPont Experimental Station, Wilmington, Delaware (“Danisco”) and Dyadic International, Inc., a Delaware corporation having its principal office at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida (“Dyadic”). Danisco and Dyadic are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.” As used in this Agreement, capitalized terms shall have the meanings indicated in Article 1 of this Agreement or as specified elsewhere in the Agreement. Other capitalized terms used but not otherwise defined herein shall have the meanings assigned to them in the Asset Purchase Agreement.
EXHIBIT A-1 to EXECUTIVE EMPLOYMENT AGREEMENT between DYADIC INTERNATIONAL, INC. and GLENN E. NEDWIN TIME VESTED STOCK OPTION AGREEMENTStock Option Grant Agreement • March 21st, 2006 • Dyadic International Inc • Services-commercial physical & biological research • Florida
This STOCK OPTION GRANT AGREEMENT (this “Agreement”), dated as of March 16, 2006 (the “Date of Grant”), is delivered by Dyadic International, Inc. (the “Company”) to GLENN E. NEDWIN (the “Grantee”).
SERVICE FRAMEWORK AGREEMENTService Framework Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
This SERVICE FRAMEWORK AGREEMENT (this "Agreement"), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 ("Dyadic"), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 4 7151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 ("BDI Pharmaceuticals"). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the "Parties" and individually as a "Party." Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.
ContractAgreement • October 9th, 2014 • Dyadic International Inc • Industrial organic chemicals • Florida
Explanatory Note – Notes were issued in the amounts listed below to the parties indicated below on separate agreements identical in form and substance, mutatis mutandis, to this Exhibit 10.16.
AMENDMENT TO CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • January 20th, 2005 • Dyadic International Inc • Services-commercial physical & biological research
LICENSE AGREEMENTEscrow Agreement • November 20th, 2008 • Dyadic International Inc • Industrial organic chemicals • New York
This LICENSE AGREEMENT (the “Agreement”) is made as of November 14, 2008 (the “Effective Date”) by and between Codexis, Inc., a Delaware corporation, having a place of business at 200 Penobscot Drive, Redwood City, California 94063, United States of America, (“Codexis”) and Dyadic International (USA), Inc., a corporation organized under the laws of Florida, having its principal office at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094, United States of America, and Dyadic International, Inc., a Delaware corporation, having a place of business at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094, United States of America, (Dyadic International (USA), Inc. and Dyadic International, Inc., collectively, hereinafter “Dyadic”). Codexis and Dyadic are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 11th, 2024 • Dyadic International Inc • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 8, 2024, by and among Dyadic International, Inc., a Delaware corporation (the “Company”), and the parties signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTFirst Amendment • March 21st, 2006 • Dyadic International Inc • Services-commercial physical & biological research
THIS FIRST AMENDMENT (this “First Amendment”) is made and entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation (the “Company”) and MARK A. EMALFARB (the “Executive”) as of the 16th day of March, 2006.
